Miriam Provost - 23 Dec 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: VP of US Regulatory & FDA Rel.
Signature: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 23 Dec 2021
Net transactions value: +$2,846
Form type: 4
Filing time: 28 Dec 2021, 15:30:28 UTC
Previous filing: 17 Sep 2021
Next filing: 24 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$2,846	+884	+10%	$3.22^*	9,438	23 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-884	-4.1%	$0.000000	20,881	23 Dec 2021	Common Stock	884	$3.22	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date.